Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Non-Current Assets (2020 - 2025)

Selectis Health's Non-Current Assets history spans 10 years, with the latest figure at $25.0 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $25.0 million for Q4 2025, down 16.45% from a year ago — trailing twelve months through Dec 2025 was $113.7 million (down 10.02% YoY), and the annual figure for FY2025 was $25.0 million, down 16.45%.
  • Non-Current Assets for Q4 2025 was $25.0 million at Selectis Health, down from $29.3 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $39.1 million in Q1 2021 to a low of $25.0 million in Q4 2025.
  • The 5-year median for Non-Current Assets is $36.6 million (2023), against an average of $34.7 million.
  • The sharpest move saw Non-Current Assets fell 1.23% in 2022, then dropped 16.55% in 2024.
  • Year by year, Non-Current Assets stood at $39.0 million in 2021, then dropped by 3.67% to $37.5 million in 2022, then decreased by 4.83% to $35.7 million in 2023, then fell by 16.23% to $29.9 million in 2024, then dropped by 16.45% to $25.0 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $25.0 million, $29.3 million, and $29.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.